Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02357654 · ClinicalTrials.gov registry record · Phase 4
GnRH for Luteal Support in IVF/ICSI/FET Cycles
A Phase 4 study of Infertility, sponsored by University Reproductive Associates.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 350
- Enrollment target
- 1
- Study location
NCT02357654: Recruiting Phase 4 study of Infertility, sponsored by University Reproductive Associates.
NCT02357654 is a Phase 4 study of Infertility that is actively recruiting participants, run by University Reproductive Associates. The registered enrollment target is 350 participants, below the 7,585-participant average among 74 other Infertility trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02357654, a Phase 4 study of Infertility, is actively recruiting participants, sponsored by University Reproductive Associates.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 350 participants
- Enrollment target
- 1
- Study location
Study Summary
During IVF cycles an embryo is generally placed into the uterine cavity between 3 and 5 days after fertilization. For a successful pregnancy to take place, that embryo must then implant in the properly primed and staged endometrium, which subsequently must continue to develop to accommodate the growing and maturing embryo and then fetus. This process is normally regulated by hormonal interactions between the fetal, endometrial and luteal tissue. It has been found that after IVF additional support for the endometrium with progesterone improves implantation and subsequent live birth rates in IVF cycle . Recent data has shown that additional supplementation with a single administration of a GnRH agonist around the time the time of embryo transfer may further enhance these rates .
Conditions Studied
Interventions
- DRUG placebo
- DRUG GnRH
Study Locations (1)
New Jersey
- University Reproductive Associates - Hasbrouck Heights
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2015-11 |
| Est. Completion | 2026-07 |
| Phase | Phase 4 |
What NCT02357654 shows while recruiting
NCT02357654 is an interventional study that assigns participants to a tested intervention. The registered 350 participants enrollment target is mid-sized for trials with a published cap, below the 7,585-participant average among 74 other Infertility trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Infertility appearing as the primary indexed condition, and to 2 interventions - of which placebo is the first listed.
NCT02357654 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT02357654 about?
NCT02357654 is a clinical study titled "GnRH for Luteal Support in IVF/ICSI/FET Cycles". During IVF cycles an embryo is generally placed into the uterine cavity between 3 and 5 days after fertilization. For a successful pregnancy to take place, that embryo must then implant in the properly primed and staged endometrium, which subsequently must continue to develop to accommodate the grow...
What is the current status of trial NCT02357654?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 350 participants. The study started on 2015-11. Estimated completion is 2026-07.
What conditions does trial NCT02357654 study?
This clinical trial studies the following conditions: Infertility.
What interventions are being tested in trial NCT02357654?
The interventions under investigation include: placebo (DRUG), GnRH (DRUG).
Who is sponsoring clinical trial NCT02357654?
This trial is sponsored by University Reproductive Associates, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02357654 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Infertility
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02357654's enrollment target sits among peer trials
350 30th of 74 higher than 45 of 74 other Infertility trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Infertility trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Randomized Controlled Trial of Combined Letrozole and Clomid (CLC II) Versus Letrozole Alone for Women With Anovulation
ACTIVE NOT RECRUITING · Phase 4
-
Endometrial Markers and Response of Endometriosis Patients to Prolonged GnRH Agonist Prior to IVF
COMPLETED · Phase 4
-
Vaginal Compared to Intramuscular Progesterone for Frozen Embryo Transfer
COMPLETED · Phase 4
-
Concomitant Administration of FSH With HCG Improves Oocyte Maturation and Quality Double -Blinded Randomized Trial
COMPLETED · Phase 4
-
Menopur Mixed Protocol
COMPLETED · Phase 4
-
Gamete Treatment to Correct Fertilization Failure
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900575 · 350 participants · NA
Cervical Cancer Detection Using Optical Spectroscopy
- NCT01627821 · 350 participants · NA
Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study
- NCT03997370 · 350 participants · Phase 1
Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol
- NCT04042259 · 350 participants · NA
Delayed Primary Closure Using Negative Pressure Wound Therapy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia